These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19018778)

  • 1. A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment.
    Whatmore AJ; Patel L; Clayton PE
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):429-34. PubMed ID: 19018778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
    Clayton P; Chatelain P; Tatò L; Yoo HW; Ambler GR; Belgorosky A; Quinteiro S; Deal C; Stevens A; Raelson J; Croteau P; Destenaves B; Olivier C
    Eur J Endocrinol; 2013 Sep; 169(3):277-89. PubMed ID: 23761422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
    Stevens A; Clayton P; Tatò L; Yoo HW; Rodriguez-Arnao MD; Skorodok J; Ambler GR; Zignani M; Zieschang J; Della Corte G; Destenaves B; Champigneulle A; Raelson J; Chatelain P
    Pharmacogenomics J; 2014 Feb; 14(1):54-62. PubMed ID: 23567489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone on cognitive function.
    Ross JL
    Horm Res; 2005; 64 Suppl 3():89-94. PubMed ID: 16439850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
    Stevens A; Murray P; Wojcik J; Raelson J; Koledova E; Chatelain P; Clayton P;
    Eur J Endocrinol; 2016 Dec; 175(6):633-643. PubMed ID: 27651465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome.
    Susperreguy S; Miras MB; Montesinos MM; Mascanfroni ID; Muñoz L; Sobrero G; Silvano L; Masini-Repiso AM; Coleoni AH; Targovnik HM; Pellizas CG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):629-36. PubMed ID: 17666093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey.
    Yavaş Abalı Z; Darendeliler F; Neyzi O
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):490-495. PubMed ID: 27354120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
    Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
    Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
    Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
    Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GHR and VDR genes do not contribute to the growth hormone (GH) response in GH deficient and Turner syndrome patients.
    Alvarez-Nava F; Marcano H; Pardo T; Paoli M; Gunczler P; Soto M; Villaloboss J; Lanes R
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):773-82. PubMed ID: 21073120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.
    Fernández-Pérez L; Nóvoa J; Ståhlberg N; Santana-Farré R; Boronat M; Marrero D; Henríquez-Hernández L; Norstedt G; Flores-Morales A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):800-6. PubMed ID: 19849699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychological consequences of Turner syndrome and review of the National Cooperative Growth Study psychological substudy.
    Siegel PT; Clopper R; Stabler B
    Pediatrics; 1998 Aug; 102(2 Pt 3):488-91. PubMed ID: 9685450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
    Ranke MB; Lindberg A
    Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.